Shionogi Inc:企業の戦略的SWOT分析

◆英語タイトル:Shionogi Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C2741
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,875見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,625見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Shionogi Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Shionogi Inc (Shionogi), a subsidiary of Shionogi & Co., Ltd, is a pharmaceutical company that develops and commercializes pharmaceutical products to address the unmet medical needs. The company offers a wide range of branded prescription products to treat chronic diseases. It markets products for various therapeutic areas such as pain, anti-infectives, women’s health, pediatrics, cardiovascular and others. Shionogi offers its products in various formulations such as tablets, oral suspensions (solutions), lotions, capsules, chewable tablets and injections. Some of the company’s key branded products include Doribax, Fortamet, Methylin, Ponstel and Xodol, among others. Shionogi is headquartered in Florham Park, New Jersey, the US.

Shionogi Inc Key Recent Developments

May 09,2018: Shionogi to Announce Executive Appointment
Dec 12,2017: Shionogi signs strategic digital transformation agreement with Accenture

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Shionogi Inc – Key Facts 5
Shionogi Inc – Key Employees 6
Shionogi Inc – Key Employee Biographies 7
Shionogi Inc – Major Products and Services 8
Shionogi Inc – History 9
Shionogi Inc – Company Statement 12
Shionogi Inc – Locations And Subsidiaries 13
Head Office 13
Section 2 – Company Analysis 14
Company Overview 14
Shionogi Inc – Business Description 15
Shionogi Inc – SWOT Analysis 16
SWOT Analysis – Overview 16
Shionogi Inc – Strengths 16
Shionogi Inc – Weaknesses 17
Shionogi Inc – Opportunities 18
Shionogi Inc – Threats 19
Shionogi Inc – Key Competitors 20
Section 3 – Company’s Lifesciences Financial Deals and Alliances 21
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22
Shionogi Inc, Recent Deals Summary 23
Section 4 – Company’s Recent Developments 24
May 09, 2018: Shionogi to Announce Executive Appointment 24
Dec 12, 2017: Shionogi signs strategic digital transformation agreement with Accenture 25
Section 5 – Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Shionogi Inc, Key Facts 5
Shionogi Inc, Key Employees 6
Shionogi Inc, Key Employee Biographies 7
Shionogi Inc, Major Products and Services 8
Shionogi Inc, History 9
Shionogi Inc, Key Competitors 20
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22
Shionogi Inc, Recent Deals Summary 23

List of Figures
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
Shionogi Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 22

★海外企業調査レポート[Shionogi Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sejal Glass Limited (SEZAL):企業の財務・戦略的SWOT分析
    Sejal Glass Limited (SEZAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • World Reach Limited (WRR):企業の財務・戦略的SWOT分析
    World Reach Limited (WRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dah Chong Hong Holdings Ltd:企業の戦略的SWOT分析
    Dah Chong Hong Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Marmen Inc:企業の戦略的SWOT分析
    Marmen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Avesthagen Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Avesthagen Ltd (Avesthagen) is a life science company that offers preventive personalized healthcare solutions. The company offers bio-nutrition, bio-agriculture and bio-pharmaceutical products. Its bio-nutrition products include validated bio-actives from Indian medicinal plants for prevent …
  • Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on …
  • De La Rue Plc
    De La Rue Plc - Strategy, SWOT and Corporate Finance Report Summary De La Rue Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Secom Co Ltd.:企業の戦略・SWOT・財務分析
    Secom Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Secom Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Alethia Biotherapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alethia Biotherapeutics Inc (Alethia Biotherapeutics) is a biotechnology company that discovers and develops therapeutic products. The company’s products comprise AB-25E9 bone antiresorptive, AB-3A4 invasive carcinomas treatment products, and AB-16B5 EMT inhibitors. It also offers therapeuti …
  • DHL International GmbH:企業の戦略的SWOT分析
    DHL International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Naturgy Energy Group SA:企業の戦略・SWOT・財務情報
    Naturgy Energy Group SA - Strategy, SWOT and Corporate Finance Report Summary Naturgy Energy Group SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Murata Manufacturing Co Ltd (6981):企業の財務・戦略的SWOT分析
    Murata Manufacturing Co Ltd (6981) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • CoLucid Pharmaceuticals Inc (CLCD)-製薬・医療分野:企業M&A・提携分析
    Summary CoLucid Pharmaceuticals Inc (CoLucid) is a pharmaceutical company that conducts research and develops new therapies. CoLucid’s lead product candidate Lasmiditan (COL-144), is an oral tablet that penetrates the central nervous system and selectively targets 5-HT1F receptors expressed in the t …
  • Mahle GmbH:企業の戦略的SWOT分析
    Mahle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Caladrius Biosciences Inc (CLBS)-医療機器分野:企業M&A・提携分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc is a clinical stage development company that develops and manufactures cell therapy products. The company’s products are based on its proprietary technologies such as Dendritic Cell-Tumor Cell technology; CD34 technology; and T Regu …
  • Brinker International, Inc.:企業の戦略・SWOT・財務分析
    Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bracco Imaging SpA:医療機器:M&Aディール及び事業提携情報
    Summary Bracco Imaging SpA (Bracco), a subsidiary of Bracco SpA, is a provider of diagnostic imaging solutions. The company offers diagnostic imaging, bracco pharma and health services. It offers solutions which include X-Ray, CT colonography, magnetic resonance imaging, diagnostic radiology, endosc …
  • Themis Medicare Ltd (THEMISMED):企業の財務・戦略的SWOT分析
    Summary Themis Medicare Ltd (Themis Medicare), a subsidiary of Gedeon Richter Plc is a differentiated injectables developer that manufactures and markets pharmaceutical and healthcare products. The company’s products include formulations, original products, active pharmaceutical ingredients and diet …
  • Veloxis Pharmaceuticals AS (VELO):製薬・医療:M&Aディール及び事業提携情報
    Summary Veloxis Pharmaceuticals A/S (Veloxis) is a specialty pharmaceutical company that identifies, develops and commercializes pharmaceutical drugs in transplantation and adjacent therapies. The company developed ENVARSUS XR (tacrolimus extended-release tablets) for the prophylaxis of organ reject …
  • Murphy USA Inc:企業の戦略・SWOT・財務分析
    Murphy USA Inc - Strategy, SWOT and Corporate Finance Report Summary Murphy USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆